Comparison 3. Response at follow‐up phase (4‐6 months).
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Milnacipran vs TCAs | 1 | 107 | Odds Ratio (M‐H, Random, 95% CI) | 0.72 [0.33, 1.55] |
1.1 Milnacipran vs Clomipramine | 1 | 107 | Odds Ratio (M‐H, Random, 95% CI) | 0.72 [0.33, 1.55] |